tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NURPF Stock Latest News

Neuren Pharmaceuticals Sees Surge in H1 Revenue
Company AnnouncementsNeuren Pharmaceuticals Sees Surge in H1 Revenue
24d ago
Neuren Pharmaceuticals Posts Sharp Profit Decline
PremiumCompany Announcements
Neuren Pharmaceuticals Posts Sharp Profit Decline
24d ago
Neuren Aims to Transform Neurodevelopmental Care
PremiumCompany Announcements
Neuren Aims to Transform Neurodevelopmental Care
1M ago
Neuren Pharmaceuticals Director Increases Stake
PremiumCompany Announcements
Neuren Pharmaceuticals Director Increases Stake
1M ago
Neuren Pharmaceuticals Reports Phase 2 Trial Milestone
PremiumCompany Announcements
Neuren Pharmaceuticals Reports Phase 2 Trial Milestone
1M ago
Neuren’s Trial Suggests Breakthrough in Angelman Syndrome
PremiumCompany AnnouncementsNeuren’s Trial Suggests Breakthrough in Angelman Syndrome
1M ago
Neuren Pharmaceuticals Awaits Key Clinical Trial Results
Premium
Company Announcements
Neuren Pharmaceuticals Awaits Key Clinical Trial Results
1M ago
Neuren Pharma’s Q2 Growth and Clinical Advances
Premium
Company Announcements
Neuren Pharma’s Q2 Growth and Clinical Advances
1M ago
Neuren Pharma Reports Major Shareholder Change
PremiumCompany Announcements
Neuren Pharma Reports Major Shareholder Change
2M ago
Leadership Shift at Neuren Pharmaceuticals
PremiumCompany Announcements
Leadership Shift at Neuren Pharmaceuticals
3M ago
Neuren Pharmaceuticals Expands Market Presence
PremiumCompany Announcements
Neuren Pharmaceuticals Expands Market Presence
3M ago
Neuren Pharma Director Ups Shareholding
PremiumCompany Announcements
Neuren Pharma Director Ups Shareholding
3M ago
Neuren Pharmaceuticals Targets Neurodevelopmental Progress
PremiumCompany AnnouncementsNeuren Pharmaceuticals Targets Neurodevelopmental Progress
4M ago
Neuren Pharmaceuticals’ Lucrative Year with DAYBUE Success
Premium
Company Announcements
Neuren Pharmaceuticals’ Lucrative Year with DAYBUE Success
4M ago
Neuren Pharmaceuticals Reveals Promising Trial Results
Premium
Company Announcements
Neuren Pharmaceuticals Reveals Promising Trial Results
4M ago
Neuren’s NNZ-2591 Shows Promise for Pitt Hopkins
PremiumCompany Announcements
Neuren’s NNZ-2591 Shows Promise for Pitt Hopkins
4M ago
Neuren Pharmaceuticals Awaits Key Trial Results
PremiumCompany Announcements
Neuren Pharmaceuticals Awaits Key Trial Results
4M ago
Neuren Pharma Addresses Neurodevelopmental Challenges
PremiumCompany Announcements
Neuren Pharma Addresses Neurodevelopmental Challenges
4M ago
Neuren’s DAYBUE™ Shows Strong Q1 Sales and Global Expansion
PremiumCompany Announcements
Neuren’s DAYBUE™ Shows Strong Q1 Sales and Global Expansion
4M ago
Neuren Pharmaceuticals Announces Option Cessation
PremiumCompany AnnouncementsNeuren Pharmaceuticals Announces Option Cessation
5M ago
Neuren Pharmaceuticals Cancels 150,000 Options
Premium
Company Announcements
Neuren Pharmaceuticals Cancels 150,000 Options
5M ago
Neuren Pharmaceuticals Virtual Meeting Guide
Premium
Company Announcements
Neuren Pharmaceuticals Virtual Meeting Guide
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >